Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1383717-52-9

Post Buying Request

1383717-52-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1383717-52-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1383717-52-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,3,7,1 and 7 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1383717-52:
(9*1)+(8*3)+(7*8)+(6*3)+(5*7)+(4*1)+(3*7)+(2*5)+(1*2)=179
179 % 10 = 9
So 1383717-52-9 is a valid CAS Registry Number.

1383717-52-9Downstream Products

1383717-52-9Relevant articles and documents

Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold

Taddei, Maurizio,Ferrini, Serena,Giannotti, Luca,Corsi, Massimo,Manetti, Fabrizio,Giannini, Giuseppe,Vesci, Loredana,Milazzo, Ferdinando M.,Alloatti, Domenico,Guglielmi, Mario B.,Castorina, Massimo,Cervoni, Maria L.,Barbarino, Marcella,Foderà, Rosanna,Carollo, Valeria,Pisano, Claudio,Armaroli, Silvia,Cabri, Walter

, p. 2258 - 2274 (2014/04/17)

Ruthenium catalyzed 1,3-cycloaddition (click chemistry) of an azido moiety installed on dihydroxycumene scaffold with differently substituted aryl propiolates gave a new family of 1,4,5-trisubstituted triazole carboxylic acid derivatives that showed high affinity toward Hsp90 associated with cell proliferation inhibition, both in nanomolar range. The 1,5 arrangement of the resorcinol, the aryl moieties, and the presence of an alkyl (secondary) amide in position 4 of the triazole ring were essential to get high activity. Docking simulations suggested that the triazoles penetrate the Hsp90 ATP binding site. Some 1,4,5-trisubstituted triazole carboxamides induced dramatic depletion of the examined client proteins and a very strong increase in the expression levels of the chaperone Hsp70. In vitro metabolic stability and in vivo preliminary studies on selected compounds have shown promising results comparable to the potent Hsp90 inhibitor NVP-AUY922. One of them, (compound 18, SST0287CL1) was selected for further investigation as the most promising drug candidate.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1383717-52-9